Lésions nécrotiques de la face au cours de la maladie de Kawasaki

Kourda, M.; Bouaziz, Asma; Tougourti, M. N.

doi:10.1016/j.arcped.2010.08.012

Cited by 3 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… Urinary system : aseptic pyuria , proteinuria, urethritis, testicular swelling. Skin : erythema and induration at the site of a previous bacillus Calmette-Guérin vaccination [ 82 ]. Respiratory system : cough, rhinorrea, slow-resolution pneumonia, pulmonary nodules, and lung infiltrates.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

et al. 2018

View full text Add to dashboard Cite

The primary purpose of these practical guidelines related to Kawasaki disease (KD) is to contribute to prompt diagnosis and appropriate treatment on the basis of different specialists’ contributions in the field. A set of 40 recommendations is provided, divided in two parts: the first describes the definition of KD, its epidemiology, etiopathogenetic hints, presentation, clinical course and general management, including treatment of the acute phase, through specific 23 recommendations.Their application is aimed at improving the rate of treatment with intravenous immunoglobulin and the overall potential development of coronary artery abnormalities in KD. Guidelines, however, should not be considered a norm that limits treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient’s condition, and disease severity or complications.

show abstract

Section: Introductionmentioning

confidence: 99%

“…Skin : erythema and induration at the site of a previous bacillus Calmette-Guérin vaccination [ 82 ].…”

Section: Introductionmentioning

confidence: 99%

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

et al. 2018

View full text Add to dashboard Cite

show abstract

Cutaneous Vasculitis

Chang¹,

Weiss²

2019

Harper's Textbook of Pediatric Dermatology

View full text Add to dashboard Cite

Kawasaki disease in Kenya and review of the African literature

Migowa,

Njeru,

Were

et al. 2024

Pediatr Rheumatol

View full text Add to dashboard Cite

Background Kawasaki disease has been described across the globe, although publications from Africa are limited. To our knowledge, there are no publications on Kawasaki disease from Kenya, which triggered this report. Methods A retrospective cross-sectional study was undertaken to identify in-patients with a discharge diagnosis of Kawasaki disease, over 2 different 5-year periods, at two pediatric hospitals in Nairobi, Kenya. We reviewed the medical records of all patients and report their clinical findings, diagnostic workup and treatment. In addition, we undertook a detailed review of the literature. Results Twenty-three patients with Kawasaki disease were identified, of those 12 (52.2%) had incomplete disease. The mean age was 2.3 years (SD+/-2.2) (range 0.3–10.3) with a male to female ratio of 1:1. The mean duration of fever at diagnosis was 8.3 days (SD+/-4.7) (range 2–20). Oral changes were the most common clinical feature and conjunctivitis the least common. Thrombocytosis at diagnosis was seen in 52% (12/23). Twenty-one patients (91.3%) were treated with intravenous immunoglobulin and all except 1 received aspirin. Baseline echocardiograms were performed in 95.7% (22/23) and found to be abnormal in 3 (13.6%). Follow-up data was limited. Our literature review identified 79 publications with documented cases of Kawasaki disease in children from 22 countries across the African continent with a total of 1115 patients including those from this report. Only 153 reported cases, or 13.7%, are from sub-Saharan Africa. Conclusions This is the first publication on Kawasaki disease from Kenya and one of the largest reports from sub-Saharan Africa. It is the first to have a complete review of the number of published cases from the African continent. Challenges in the diagnosis and management of Kawasaki disease in many African countries include disease awareness, infectious confounders, access and cost of intravenous immunoglobulin, access to pediatric echocardiography and follow-up. Increasing awareness and health care resources are important for improving outcomes of Kawasaki disease in Africa.

show abstract

Lésions nécrotiques de la face au cours de la maladie de Kawasaki

Cited by 3 publications

References 5 publications

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

Cutaneous Vasculitis

Kawasaki disease in Kenya and review of the African literature

Contact Info

Product

Resources

About